Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Losartan versus amlodipine in hospitalized patients with COVID-19
IRCT20180802040678N4Phase 3Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of losartan in coronavirus disease 2019 (COVID-19), sponsored by Tabriz University of Medical Sciences. Primary endpoints: 28-day mortality, Length of hospitalization and 3 more. Started Mar 2020; status: completed.
02
Drugs
losartan
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on IRCT20180802040678N4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180802040678N4.